BARCELONA (Reuters) -Spanish drugmaker Grifols on Tuesday lifted its 2023 margin outlook after reporting sturdy growth in first-quarter core earnings and revenue as cost-cutting...
By Joan Faus BARCELONA (Reuters) -Grifols said on Monday its executive chairman Thomas Glanzmann will become its new chief executive with immediate effect, ending the founding...
By Joan Faus and Matteo Allievi BARCELONA (Reuters) -Spanish pharmaceutical company Grifols' shares fell around 10% in afternoon trading after its 2023 outlook disappointed...
MADRID (Reuters) - Steven F. Mayer has resigned as executive chairman of the board of Spanish pharmaceutical company Grifols, the company said on Tuesday, citing health and other...
(Reuters) - Spanish pharmaceutical firm Grifols shares climbed 8% on Thursday, a day after the company announced plans to lay off around 2,300 employees, or 8.5% of its global...
BARCELONA (Reuters) - Spanish pharmaceutical firm Grifols plans to lay off around 2,300 employees, or 8.5% of its global workforce, amid a strategy overhaul aimed at reaching...
By Daniel Shvartsman Investing.com - European markets opened higher to kick off trading in the shortened last week of the year. At 03:10 ET (08:10 GMT), the DAX was up 0.8%, the...
Benzinga - On Wednesday, shares of Grifols Sa (OTC: GIKLY) experienced volatile short activity. After the activity, the stock price went up +0% to $5.93. The overall sentiment for...
MADRID (Reuters) - Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs. Grifols said it was still on...
MADRID (Reuters) - Spanish pharma group Grifols said on Friday a lawsuit filed in the United States by blood donors who claim the company violated their privacy would have no...